Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.
暂无分享,去创建一个
Dalong Ni | Weibo Cai | Jianlin Shi | Emily B. Ehlerding | W. Cai | Jianlin Shi | Dalong Ni | W. Bu | Wenbo Bu | Wenbo Bu
[1] Zhi-Jun Liu,et al. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity. , 2013, Nanoscale.
[2] In Su Lee,et al. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. , 2009, Angewandte Chemie.
[3] V. Pierre,et al. Next generation, high relaxivity gadolinium MRI agents. , 2005, Bioconjugate chemistry.
[4] Taeghwan Hyeon,et al. Inorganic Nanoparticles for MRI Contrast Agents , 2009 .
[5] E. Haacke,et al. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.
[6] F. Fang,et al. Anchoring Group Effects of Surface Ligands on Magnetic Properties of Fe3O4 Nanoparticles: Towards High Performance MRI Contrast Agents , 2014, Advanced materials.
[7] H. Daldrup-Link,et al. Macrophage phagocytosis alters the MRI signal of ferumoxytol-labeled mesenchymal stromal cells in cartilage defects , 2016, Scientific Reports.
[8] Jianlin Shi,et al. In Vivo Bio‐Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles , 2013, Advanced materials.
[9] Shuo Shi,et al. Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography. , 2017, ACS nano.
[10] Xin Yu,et al. Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T1 shortening , 2013, Nanotechnology.
[11] Zhuxian Zhou,et al. Gadolinium-based contrast agents for magnetic resonance cancer imaging. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[12] Xiaoyuan Chen,et al. Tumor Microenvironment‐Triggered Supramolecular System as an In Situ Nanotheranostic Generator for Cancer Phototherapy , 2017, Advanced materials.
[13] Bongsoo Kim,et al. Size-dependent magnetic properties of colloidal Mn(3)O(4) and MnO nanoparticles. , 2004, Angewandte Chemie.
[14] Andrew Y. Wang,et al. Preparation and control of the formation of single core and clustered nanoparticles for biomedical applications using a versatile amphiphilic diblock copolymer , 2010 .
[15] Shreya Mukherjee,et al. Redox-activated manganese-based MR contrast agent. , 2013, Journal of the American Chemical Society.
[16] Jinwoo Cheon,et al. Recent advances in magnetic nanoparticle-based multi-modal imaging. , 2015, Chemical Society reviews.
[17] Liangping Zhou,et al. Gd3+‐Ion‐Doped Upconversion Nanoprobes: Relaxivity Mechanism Probing and Sensitivity Optimization , 2013 .
[18] A Paul Alivisatos,et al. Localized surface plasmon resonances arising from free carriers in doped quantum dots. , 2011, Nature materials.
[19] W. Tremel,et al. Au@MnO nanoflowers: hybrid nanocomposites for selective dual functionalization and imaging. , 2010, Angewandte Chemie.
[20] Q. Song,et al. Shape control and associated magnetic properties of spinel cobalt ferrite nanocrystals. , 2004, Journal of the American Chemical Society.
[21] Xiwen He,et al. Facile synthesis of functional gadolinium-doped CdTe quantum dots for tumor-targeted fluorescence and magnetic resonance dual-modality imaging. , 2014, Journal of materials chemistry. B.
[22] L. Prodi,et al. Imaging agents based on lanthanide doped nanoparticles. , 2015, Chemical Society reviews.
[23] Tymish Y. Ohulchanskyy,et al. Combined Optical and MR Bioimaging Using Rare Earth Ion Doped NaYF4 Nanocrystals , 2009 .
[24] E. Terreno,et al. Improved paramagnetic liposomes for MRI visualization of pH triggered release. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[25] G. Angelovski. Heading toward Macromolecular and Nanosized Bioresponsive MRI Probes for Successful Functional Imaging. , 2017, Accounts of chemical research.
[26] Thomas Meade,et al. Effects of shape and size of cobalt ferrite nanostructures on their MRI contrast and thermal activation. , 2009, The journal of physical chemistry. C, Nanomaterials and interfaces.
[27] Samuel A Wickline,et al. Manganese-based MRI contrast agents: past, present and future. , 2011, Tetrahedron.
[28] Yiwei Chen,et al. Gadolinium-doped carbon dots with high quantum yield as an effective fluorescence and magnetic resonance bimodal imaging probe , 2016 .
[29] Yongmin Chang,et al. A facile synthesis, in vitro and in vivo MR studies of d-glucuronic acid-coated ultrasmall Ln₂O₃ (Ln = Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent. , 2011, ACS applied materials & interfaces.
[30] B. Rutt,et al. Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells , 2002, Magnetic resonance in medicine.
[31] Kai Yang,et al. Perfluorocarbon‐Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near‐Infrared Light to Enhance the Radiotherapy of Cancer , 2016, Advanced materials.
[32] Sumaira Ashraf,et al. In vivo degeneration and the fate of inorganic nanoparticles. , 2016, Chemical Society reviews.
[33] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[34] Kai Yang,et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. , 2011, Angewandte Chemie.
[35] Grigory Tikhomirov,et al. Caspase-responsive smart gadolinium-based contrast agent for magnetic resonance imaging of drug-induced apoptosis. , 2014, Chemical science.
[36] G. Brudvig,et al. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. , 2011, ACS nano.
[37] L. Lartigue,et al. Biotransformations of magnetic nanoparticles in the body , 2016 .
[38] S. Nie,et al. Reexamining the Effects of Particle Size and Surface Chemistry on the Magnetic Properties of Iron Oxide Nanocrystals: New Insights into Spin Disorder and Proton Relaxivity , 2008 .
[39] Kai Yang,et al. Catalase‐Loaded TaOx Nanoshells as Bio‐Nanoreactors Combining High‐Z Element and Enzyme Delivery for Enhancing Radiotherapy , 2016, Advanced materials.
[40] Patrick Couvreur,et al. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. , 2012, Chemical reviews.
[41] R. Reilly,et al. What nephrologists need to know about gadolinium , 2007, Nature Clinical Practice Nephrology.
[42] Jianlin Shi,et al. Silica coated upconversion nanoparticles: a versatile platform for the development of efficient theranostics. , 2015, Accounts of chemical research.
[43] Marc Vendrell,et al. Intracellular glutathione detection using MnO(2)-nanosheet-modified upconversion nanoparticles. , 2011, Journal of the American Chemical Society.
[44] Gang Bao,et al. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. , 2016, Nanomedicine.
[45] Mark D Pagel,et al. A review of responsive MRI contrast agents: 2005-2014. , 2015, Contrast media & molecular imaging.
[46] Weihong Tan,et al. Activatable fluorescence/MRI bimodal platform for tumor cell imaging via MnO2 nanosheet-aptamer nanoprobe. , 2014, Journal of the American Chemical Society.
[47] P. Perriat,et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. , 2007, Journal of the American Chemical Society.
[48] Ick Chan Kwon,et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. , 2012, Chemical Society reviews.
[49] G. Bao,et al. Size-Dependent Heating of Magnetic Iron Oxide Nanoparticles. , 2017, ACS nano.
[50] Liangzhu Feng,et al. Intelligent Albumin–MnO2 Nanoparticles as pH‐/H2O2‐Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy , 2016, Advanced materials.
[51] Yang Sun,et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. , 2012, Biomaterials.
[52] M. Hoehn,et al. Polyelectrolyte coating of iron oxide nanoparticles for MRI-based cell tracking. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[53] Mauro Ferrari,et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast , 2010, Nature nanotechnology.
[54] Xiaoyuan Chen,et al. Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.
[55] Jie Zheng,et al. PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles. , 2013, Angewandte Chemie.
[56] R. Pei,et al. Gadolinium-based nanoscale MRI contrast agents for tumor imaging. , 2017, Journal of materials chemistry. B.
[57] Jin-Sil Choi,et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets. , 2017, Nature materials.
[58] S. Laurent,et al. High Relaxivities and Strong Vascular Signal Enhancement for NaGdF4 Nanoparticles Designed for Dual MR/Optical Imaging , 2013, Advanced healthcare materials.
[59] Daniela A Wilson,et al. Manipulation of micro- and nanostructure motion with magnetic fields. , 2014, Soft matter.
[60] I. Aoki,et al. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy. , 2016, Nature nanotechnology.
[61] B. Bay,et al. Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent. , 2017, ACS nano.
[62] Erik Kampert,et al. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent. , 2008, Journal of the American Chemical Society.
[63] Anna Moore,et al. In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.
[64] Arno C Gutleb,et al. Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles. , 2017, ACS nano.
[65] Hakho Lee,et al. Recent Developments in Magnetic Diagnostic Systems. , 2015, Chemical reviews.
[66] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[67] E. Gianolio,et al. An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent. , 2015, ACS nano.
[68] R. V. Van Duyne,et al. Localized surface plasmon resonance spectroscopy and sensing. , 2007, Annual review of physical chemistry.
[69] Dong Chen,et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.
[70] Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. , 2005, Journal of the American Chemical Society.
[71] S. Hurley,et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. , 2010, ACS nano.
[72] Wenpei Fan,et al. Real-time in vivo quantitative monitoring of drug release by dual-mode magnetic resonance and upconverted luminescence imaging. , 2014, Angewandte Chemie.
[73] Hsuan-Liang Liu,et al. Preparation of ICG-FePt nanoparticles promising for magnetic resonance imaging contrast agent and hyperthermia applications , 2016 .
[74] S. Moon,et al. Ultrathin Interface Regime of Core-Shell Magnetic Nanoparticles for Effective Magnetism Tailoring. , 2017, Nano letters.
[75] Enzo Terreno,et al. Lanthanide(III) chelates for NMR biomedical applications , 1998 .
[76] Taeghwan Hyeon,et al. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. , 2012, Chemical Society reviews.
[77] Shelton D Caruthers,et al. Revisiting an old friend: manganese-based MRI contrast agents. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[78] Shuming Nie,et al. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. , 2008, Small.
[79] In Su Lee,et al. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI. , 2013, Biomaterials.
[80] R. Prosser,et al. Water-Soluble GdF3 and GdF3/LaF3 NanoparticlesPhysical Characterization and NMR Relaxation Properties , 2006 .
[81] Weili Lin,et al. Mesoporous silica nanospheres as highly efficient MRI contrast agents. , 2008, Journal of the American Chemical Society.
[82] Zhen Cheng,et al. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. , 2010, ACS nano.
[83] Scott E. Fraser,et al. In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.
[84] Dwight G Nishimura,et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents , 2006, Nature materials.
[85] Xiaolian Sun,et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. , 2017, Chemical Society reviews.
[86] Taeghwan Hyeon,et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. , 2011, Journal of the American Chemical Society.
[87] Liangping Zhou,et al. Ultrasmall NaGdF4 Nanodots for Efficient MR Angiography and Atherosclerotic Plaque Imaging , 2014, Advanced materials.
[88] Yongmin Chang,et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. , 2009, ACS nano.
[89] Han Lin,et al. Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy. , 2017, Journal of the American Chemical Society.
[90] Yongmin Chang,et al. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents. , 2012, Biomaterials.
[91] Rui Tian,et al. Artificial local magnetic field inhomogeneity enhances T2 relaxivity , 2017, Nature Communications.
[92] Lianzhou Wang,et al. Break‐up of Two‐Dimensional MnO2 Nanosheets Promotes Ultrasensitive pH‐Triggered Theranostics of Cancer , 2014, Advanced materials.
[93] Taeghwan Hyeon,et al. Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.
[94] Eun-Kyung Lim,et al. pH‐Triggered Drug‐Releasing Magnetic Nanoparticles for Cancer Therapy Guided by Molecular Imaging by MRI , 2011, Advanced materials.
[95] M. Hiraoka,et al. Monitoring of biological one-electron reduction by (19)F NMR using hypoxia selective activation of an (19)F-labeled indolequinone derivative. , 2009, Journal of the American Chemical Society.
[96] B. Sitharaman,et al. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. , 2005, Journal of the American Chemical Society.
[97] Hui Mao,et al. Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles , 2012, Theranostics.
[98] Bing Xu,et al. Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. , 2008, Journal of the American Chemical Society.
[99] R. Wu,et al. Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent. , 2016, ACS nano.
[100] Jie Zheng,et al. Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. , 2015, ACS nano.
[101] Mingyuan Gao,et al. Magnetic/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo. , 2013, ACS nano.
[102] A. Almutairi,et al. Compact Micellization: A Strategy for Ultrahigh T1 Magnetic Resonance Contrast with Gadolinium-Based Nanocrystals. , 2016, ACS nano.
[103] Jianlin Shi,et al. PEGylated NaHoF4 nanoparticles as contrast agents for both X-ray computed tomography and ultra-high field magnetic resonance imaging. , 2016, Biomaterials.
[104] A. Koretsky,et al. The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes. , 2012, Biomaterials.
[105] Goran Angelovski,et al. What We Can Really Do with Bioresponsive MRI Contrast Agents. , 2016, Angewandte Chemie.
[106] Ming Zhao,et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.
[107] Taeghwan Hyeon,et al. Theranostic Probe Based on Lanthanide‐Doped Nanoparticles for Simultaneous In Vivo Dual‐Modal Imaging and Photodynamic Therapy , 2012, Advanced materials.
[108] M. Busquets,et al. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents , 2015, International journal of nanomedicine.
[109] Sung Tae Kim,et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. , 2007, Angewandte Chemie.
[110] A. Sherry,et al. Oxidative Conversion of a Europium(II)-Based T1 Agent into a Europium(III)-Based paraCEST Agent that can be Detected In Vivo by Magnetic Resonance Imaging. , 2016, Angewandte Chemie.
[111] Y. Gossuin,et al. MnO-labeled cells: positive contrast enhancement in MRI. , 2012, The journal of physical chemistry. B.
[112] Aiguo Wu,et al. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging. , 2017, Molecular pharmaceutics.
[113] S. Zou,et al. Engineered gadolinium-doped carbon dots for magnetic resonance imaging-guided radiotherapy of tumors. , 2017, Biomaterials.
[114] Giorgio Russolillo,et al. Partial least squares algorithms and methods , 2013 .
[115] Xiaoxia Du,et al. Silica‐Coated Manganese Oxide Nanoparticles as a Platform for Targeted Magnetic Resonance and Fluorescence Imaging of Cancer Cells , 2010 .
[116] K. Zhong,et al. Casp3/7-Instructed Intracellular Aggregation of Fe3O4 Nanoparticles Enhances T2 MR Imaging of Tumor Apoptosis. , 2016, Nano letters.
[117] Lianzhou Wang,et al. Multifunctional Graphene Oxide‐based Triple Stimuli‐Responsive Nanotheranostics , 2014 .
[118] Chenjie Xu,et al. Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. , 2008, Journal of the American Chemical Society.
[119] A. Lu,et al. Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.
[120] Xiue Jiang,et al. MnO2 Gatekeeper: An Intelligent and O2‐Evolving Shell for Preventing Premature Release of High Cargo Payload Core, Overcoming Tumor Hypoxia, and Acidic H2O2‐Sensitive MRI , 2017 .
[121] A. Roch,et al. Superparamagnetic colloid suspensions: Water magnetic relaxation and clustering , 2005 .
[122] Yan Zhang,et al. Single-Phase Dy2O3:Tb3+ Nanocrystals as Dual-Modal Contrast Agent for High Field Magnetic Resonance and Optical Imaging , 2011 .
[123] M. Botta,et al. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules. , 2006, Inorganic chemistry.
[124] J. Morrow,et al. A redox-activated MRI contrast agent that switches between paramagnetic and diamagnetic states. , 2013, Angewandte Chemie.
[125] Sik-Yum Lee,et al. Bayesian structural equation model , 2014 .
[126] S. H. Koenig,et al. Transverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite , 1987, Magnetic resonance in medicine.
[127] L. Helm,et al. Water exchange on metal ions: experiments and simulations , 1999 .
[128] Oliver T. Bruns,et al. A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. , 2009, Nano letters.
[129] S. Gambhir,et al. Nanomaterials for In Vivo Imaging. , 2017, Chemical reviews.
[130] J. Duerk,et al. Magnetite‐Loaded Polymeric Micelles as Ultrasensitive Magnetic‐Resonance Probes , 2005 .
[131] Ming Ma,et al. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery. , 2012, Biomaterials.
[132] Teruyuki Kondo,et al. Size‐Controlled and Biocompatible Gd2O3 Nanoparticles for Dual Photoacoustic and MR Imaging , 2012, Advanced healthcare materials.
[133] Chad A Mirkin,et al. Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. , 2009, Angewandte Chemie.
[134] R. Weissleder,et al. Molecular imaging in drug discovery and development , 2003, Nature Reviews Drug Discovery.
[135] Xiaoyuan Chen,et al. Color-tunable Gd-Zn-Cu-In-S/ZnS quantum dots for dual modality magnetic resonance and fluorescence imaging , 2014, Nano Research.
[136] Xiaoqun Gong,et al. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo. , 2015, ACS nano.
[137] Chung-Yuan Mou,et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. , 2008, Small.
[138] Meng-Lin Li,et al. Infrared-active quadruple contrast FePt nanoparticles for multiple scale molecular imaging. , 2016, Biomaterials.
[139] Stefan Vogt,et al. DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. , 2007, Journal of the American Chemical Society.
[140] Oliver T. Bruns,et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. , 2007, Nano letters.
[141] Taeghwan Hyeon,et al. Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem Cells , 2011, Journal of the American Chemical Society.
[142] R. Brooks,et al. On T2‐shortening by strongly magnetized spheres: A partial refocusing model , 2002, Magnetic resonance in medicine.
[143] Z. Fayad,et al. Clearance of Iron Oxide Particles in Rat Liver: Effect of Hydrated Particle Size and Coating Material on Liver Metabolism , 2006, Investigative radiology.
[144] Chunhua Yan,et al. PAA-capped GdF3 nanoplates as dual-mode MRI and CT contrast agents , 2015 .
[145] Xiaogang Liu,et al. Preparation of core-shell NaGdF4 nanoparticles doped with luminescent lanthanide ions to be used as upconversion-based probes , 2014, Nature Protocols.
[146] Zijian Zhou,et al. Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability. , 2016, Nanoscale.
[147] Jianlin Shi,et al. Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia. , 2017, Chemical reviews.
[148] Jianlin Shi,et al. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles. , 2016, Journal of the American Chemical Society.
[149] Qingfeng Xiao,et al. Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. , 2014, ACS nano.
[150] P. Callaghan,et al. Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging. , 2011, Angewandte Chemie.
[151] Yong-Min Huh,et al. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging. , 2011, Angewandte Chemie.
[152] Francis Vocanson,et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[153] Jinwoo Cheon,et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.
[154] Laura M Ensign,et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. , 2016, Advanced drug delivery reviews.
[155] Lianzhou Wang,et al. Positive and Negative Lattice Shielding Effects Co‐existing in Gd (III) Ion Doped Bifunctional Upconversion Nanoprobes , 2011 .
[156] Efstathios Karathanasis,et al. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. , 2014, Nanomedicine.
[157] Yuancheng Li,et al. Exerting Enhanced Permeability and Retention Effect Driven Delivery by Ultrafine Iron Oxide Nanoparticles with T1-T2 Switchable Magnetic Resonance Imaging Contrast. , 2017, ACS nano.
[158] A. Alivisatos. Semiconductor Clusters, Nanocrystals, and Quantum Dots , 1996, Science.
[159] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[160] Matthias Ernst,et al. Cancer research: past, present and future , 2011, Nature Reviews Cancer.
[161] Teri W. Odom,et al. Shape-Dependent Relaxivity of Nanoparticle-Based T1 Magnetic Resonance Imaging Contrast Agents. , 2016, The journal of physical chemistry. C, Nanomaterials and interfaces.
[162] Jianlin Shi. On the synergetic catalytic effect in heterogeneous nanocomposite catalysts. , 2013, Chemical reviews.
[163] Armando J. Marenco,et al. Design and Regulation of NaHoF4 and NaDyF4 Nanoparticles for High-Field Magnetic Resonance Imaging , 2016 .
[164] Elke Debroye,et al. Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging. , 2014, Chemical Society reviews.
[165] Boguslaw Tomanek,et al. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging. , 2012, The journal of physical chemistry letters.
[166] Alke Petri-Fink,et al. Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine. , 2017, Chemical reviews.
[167] Yaming Zhou,et al. Single Molecular Wells–Dawson‐Like Heterometallic Cluster for the In Situ Functionalization of Ordered Mesoporous Carbon: A T 1‐ and T 2‐Weighted Dual‐Mode Magnetic Resonance Imaging Agent and Drug Delivery System , 2017 .
[168] Ralph Weissleder,et al. Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.
[169] Ioannis Lavdas,et al. CXCR4-Targeted and MMP-Responsive Iron Oxide Nanoparticles for Enhanced Magnetic Resonance Imaging** , 2014, Angewandte Chemie.
[170] F. Fang,et al. NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo. , 2013, ACS Nano.
[171] Joop A. Peters,et al. MRI contrast agents based on dysprosium or holmium. , 2011, Progress in nuclear magnetic resonance spectroscopy.
[172] C. Yeh,et al. Synthesis of Gd doped CdSe nanoparticles for potential optical and MR imaging applications , 2010 .
[173] Jianlin Shi,et al. Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors. , 2015, Angewandte Chemie.
[174] F. Fang,et al. Rational design of multifunctional magnetic mesoporous silica nanoparticle for tumor-targeted magnetic resonance imaging and precise therapy. , 2016, Biomaterials.
[175] Kajsa Uvdal,et al. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[176] Chen Chang,et al. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. , 2008, Small.
[177] Jinwoo Cheon,et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.
[178] T. Hyeon,et al. Paramagnetic inorganic nanoparticles as T1 MRI contrast agents. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[179] Feng Chen,et al. Biodegradable and Renal Clearable Inorganic Nanoparticles , 2015, Advanced science.
[180] Liming Nie,et al. T1-T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents. , 2017, ACS nano.
[181] Dong Chen,et al. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.
[182] H. Daldrup-Link,et al. Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent. , 2015, ACS Nano.
[183] I. Solomon. Relaxation Processes in a System of Two Spins , 1955 .
[184] Wenyong Hu,et al. The properties of Gd2O3-assembled silica nanocomposite targeted nanoprobes and their application in MRI. , 2012, Biomaterials.
[185] Ichio Aoki,et al. Manganese‐enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations , 2004, NMR in biomedicine.
[186] Mathieu L. Viger,et al. Collective activation of MRI agents via encapsulation and disease-triggered release. , 2013, Journal of the American Chemical Society.
[187] Seung-Min Park,et al. Towards clinically translatable in vivo nanodiagnostics. , 2017, Nature reviews. Materials.
[188] Yaping Li,et al. Ultrasmall Confined Iron Oxide Nanoparticle MSNs as a pH‐Responsive Theranostic Platform , 2014 .
[189] S. Choi,et al. Synthesis of Uniformly Sized Manganese Oxide Nanocrystals with Various Sizes and Shapes and Characterization of Their T1 Magnetic Resonance Relaxivity , 2012 .
[190] Greg J. Stanisz,et al. Size-Tunable, Ultrasmall NaGdF4 Nanoparticles: Insights into Their T1 MRI Contrast Enhancement , 2011 .
[191] Himanshu Tyagi,et al. Iron oxide nanorods as high-performance magnetic resonance imaging contrast agents. , 2015, Nanoscale.
[192] Chung-Yuan Mou,et al. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.
[193] Teri W. Odom,et al. High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation. , 2015, ACS nano.
[194] R. Brooks,et al. On T2‐shortening by weakly magnetized particles: The chemical exchange model † , 2001, Magnetic resonance in medicine.
[195] M. Botta,et al. A Multinuclear NMR Study on the Structure and Dynamics of Lanthanide(III) Complexes of the Poly(amino carboxylate) EGTA4- in Aqueous Solution , 1997 .
[196] Jinwoo Cheon,et al. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. , 2008, Angewandte Chemie.
[197] Konstantin Nikolaou,et al. 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives , 2016, Advances in Therapy.
[198] Kazunori Kataoka,et al. PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .
[199] Lehui Lu,et al. Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging. , 2011, Biomaterials.
[200] Klaas Nicolay,et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. , 2006, Nano letters.
[201] Yang Sun,et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. , 2011, Angewandte Chemie.
[202] Shouheng Sun,et al. Recent Advances in Chemical Synthesis, Self‐Assembly, and Applications of FePt Nanoparticles , 2006 .
[203] Sophie Laurent,et al. Contrast agents: magnetic resonance. , 2008, Handbook of experimental pharmacology.
[204] C. Yeh,et al. Bifunctional Gd2O3/C Nanoshells for MR Imaging and NIR Therapeutic Applications , 2009 .
[205] D. Arifin,et al. MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted cell viability , 2012, Nature materials.
[206] Y. Hsiao,et al. A new and facile method to prepare uniform hollow MnO/functionalized mSiO₂ core/shell nanocomposites. , 2011, ACS nano.
[207] J. Martinelli,et al. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes. , 2011, Chemical communications.
[208] Robert Sinclair,et al. Redox-Triggered Self-Assembly of Gadolinium-Based MRI Probes for Sensing Reducing Environment , 2014, Bioconjugate chemistry.
[209] Dar-Bin Shieh,et al. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. , 2010, Journal of the American Chemical Society.
[210] Marco Pedroni,et al. PEG-capped, lanthanide doped GdF3 nanoparticles: luminescent and T2 contrast agents for optical and MRI multimodal imaging. , 2012, Nanoscale.
[211] Jinwoo Cheon,et al. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.
[212] Dongmei Wu,et al. Core-shell NaYF4:Yb3+,Tm3+@FexOy nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. , 2011, Biomaterials.
[213] Tao Yang,et al. Size-Tunable Gd2O3@Albumin Nanoparticles Conjugating Chlorin e6 for Magnetic Resonance Imaging-Guided Photo-Induced Therapy , 2017, Theranostics.
[214] Jianlin Shi,et al. Oxygen Vacancy Enables Markedly Enhanced Magnetic Resonance Imaging-Guided Photothermal Therapy of a Gd3+-Doped Contrast Agent. , 2017, ACS nano.
[215] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[216] Gang Bao,et al. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. , 2010, Nano letters.
[217] Prachi Pandit,et al. Controlled self-assembling of gadolinium nanoparticles as smart molecular magnetic resonance imaging contrast agents. , 2011, Angewandte Chemie.
[218] Zhi Ping Xu,et al. Manganese‐Based Layered Double Hydroxide Nanoparticles as a T1‐MRI Contrast Agent with Ultrasensitive pH Response and High Relaxivity , 2017, Advanced materials.
[219] H. Grüll,et al. Bioresponsive probes for molecular imaging: concepts and in vivo applications. , 2015, Contrast media & molecular imaging.
[220] Thierry Epicier,et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. , 2011, ACS nano.
[221] Harald Ittrich,et al. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents , 2017, Proceedings of the National Academy of Sciences.
[222] Wenpei Fan,et al. Intelligent MnO2 Nanosheets Anchored with Upconversion Nanoprobes for Concurrent pH‐/H2O2‐Responsive UCL Imaging and Oxygen‐Elevated Synergetic Therapy , 2015, Advanced materials.
[223] S. Haam,et al. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging. , 2016, Biomaterials.